Over 1750 Total Lots Up For Auction at Five Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08

MILabs launches the E-Class line of high-performance, economical PET, SPECT and, CT systems

Press releases may be edited for formatting or style | June 11, 2018 CT Molecular Imaging X-Ray
Utrecht, The Netherlands, June 8th, 2018 -- Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same system in the future.

Prof. Frederik Beekman, CEO of MILabs said: “We have an exciting new range of E-class products in our portfolio, and these high-performance, modular, standalone, and integrated imagers are economical, exceptional and field-expandable. We are enabling the cost-saving aspects by these entry level imaging systems, and we are confident that our global prospects will be enthusiastic that the E-Class PET, SPECT and CT systems are available today and can be upgraded later. With these new products, we are continuing our brand promise of “making molecular imaging clear” for all preclinical researchers.”

The E-Class systems were developed using the same advanced imaging technologies as the industry-leading VECTor system, and refined for lower cost and easy scalability. Dr. Beekman added, “The E-Class systems were built for the future needs of researchers, so they can start small, think big and scale fast”.
stats
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

stats
MILabs B.V. provides high-end molecular imaging solutions for biomedical and pharmaceutical research. These systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. For more information, visit www.milabs.com or contact us at info@milabs.com

You Must Be Logged In To Post A Comment